Share on

Global Coronary Stents Market Size, Share, Trends, Growth & COVID-19 Impact Analysis Report – Segmented By Type (Bare-metal Stents, Drug Eluting Stents & Bioabsorbable Stents), Mode Of Delivery (Balloon-expandable Stents & Self-expanding Stents), Material Type, End-User and Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 2584
Pages: 175
Formats: report pdf report excel report power bi report ppt

Coronary Stent Market Size (2022 to 2027)

As per our research report, the global coronary stent market size is forecasted to grow USD 13.81 billion by the end of 2027 from USD 9.58 billion in 2022. This market is estimated to showcase a CAGR of 7.6% during the forecast period. The coronary stent market has expanded across the world and will foresee significant growth during the forecast period. In 2020, North America was the most dominant regional market in the global coronary stent market and is expected to be continuing the same trend throughout the forecast period.

Coronary stents are small metal tubes placed in coronary arteries used to supply blood to the heart. Stent help keep arteries open and reduce the chances of narrowing again during coronary heart disease treatment. Also, percutaneous coronary intervention is used to open coronary arteries. The stent is inserted during angioplasty therapy and in an emergency to treat a heart attack disease. A cardiac physician will place the stent over a catheter and directly inserted it into an artery in the body during any heart-related procedure. Dual therapy stent is the latest type of stent in the coronary stent market.


Rising CAD diseases, technological advancements, and increasing aging populations are majorly propelling the global coronary stent market growth.

The prevalence of coronary artery diseases is growing at a rapid pace. According to the stats published by the Centers for Disease Prevention and Control (CDC), an estimated 365,914 people were dead due to Coronary heart disease in 2017, and around 6.7% of the population aged above 20 have CAD United States. This rising incidence is estimated to boost the global coronary stent market.

The rising geriatric population is another crucial factor significantly contributing to the global Coronary Stent Market growth. According to the World Health Organization (WHO), the aged population (60 or above) is expected to be around 2 billion by the end of 2050, 900 million in 2015.

Additionally, technological advances in coronary stent technology, including bifurcated stents and biodegradable materials, are likely to boost the growth rate of the coronary stent market. Rising disposable income in urban areas is merely to expand the growth of the market. With the introduction of advanced DES and evolving bioabsorbable stents, stent technology is superior to traditional balloon angioplasty. The advances in coronary stent technology and bifurcated stents use biodegradable materials have yielded effective and improved results related to CVD treatment. The market participants are active in product development, partnerships, and strategic cooperation. These factors are expected to help the global coronary stent market to scale further during the forecast period.


Developed countries with strict regulations about coronary stent use, the falling prices for these devices, and the risks associated with DES include stent thrombosis and significant global coronary stent market challenges. In addition, the disruption of endothelial tissue regeneration and its risk further limit the market growth to a limited extent.

Lack of skilled professionals in the healthcare sector, raising competitive treatment methods for artery diseases, and product failure in the real-time application hamper the coronary stent market.

COVID-19 Impact on the global coronary stent market:

The present outbreak of COVID-19 has affected the coronary stent market in many different ways. First, the supplies of raw materials for manufacturing the stents are being affected due to restrictions in the movement. Second, demand for various medical devices is projected to shorten because of delayed elective surgeries. Third, the pandemic has existed as a serious threat globally, causing a death rate and letting huge strain on healthcare resources—a challenge for health providers to treat cardiovascular disease patients during these challenging times.

The pandemic has affected coronary stents and cardiac surgeries in different ways, like beds, limited ICU beds and ventilators, and limitations in the clinical meetings. Patients already suffering from cardiac diseases may be at higher risk for deaths from the Coronavirus, including aged people. Moreover, the pandemic has threatened heart transplants' safety, and coronary stents implantations are at increased risk. The abstract of coronary stents by secondary companies across many countries has been adversely affected. There has been a reduction in demand for coronary stents, and the stock has not been sold out, negatively impacting the medical sector.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Type, Mode of delivery, material, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This research report on the global coronary stent market has been segmented and sub-segmented based on the type, mode of delivery, material, end-user, and region.

Coronary Stent Market Analysis – By Type:

  • Bare Metal Stents
  • Drug-Eluting Stents
  • Bioabsorbable Stents

The bare-metal stents type is predicted to lead the global coronary stent market during the forecast period. A rise in the incidences of cardiovascular problems is expected to accelerate the need for coronary stents. Followed by, the market is expected to be driven by bioabsorbable stents, mainly in the polylactic acid material.

However, drug-eluting stents are expected to generate significant revenue due to new advanced polymer-based products and advanced technology adoption in hospitals. DES is mainly used for coronary disease and peripheral vascular disease. The DES-based polymer has continued high manufacturing and sales in the market that fuel market growth. The bioresorbable stent segment is expected to grow in the coming years, allowing recovery of vessel vasoreactivity and endothelial functions. The majority of companies are trying to introduce the next generation of bioresorbable stents that reduce patient compliance.

Coronary Stent Market Analysis – By Mode of Delivery:

  • Balloon Expandable Stents
  • Self-Expanding Stents

Based on the mode of delivery, Balloon's expandable stent mode of delivery is expected to account for the most substantial share in the global market owing to the increasing investments in healthcare centers by private and public organizations.

Coronary Stent Market Analysis – By Material:

  • Metallic stents
    • Cobalt chromium
    • Platinum chromium
    • Nickel-titanium
    • Stainless steel
  • Other Stents

By material, the metallic stents segment has been growing faster from the past few years with the rise in healthcare expenditure, especially in urban areas.

Coronary Stent Market Analysis – By End-User:

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers

The hospital end-user is estimated to dominate the global market during the forecast period in terms of end-user. Increasing the construction activities of hospitals with the latest equipment is propelling the growth rate of this segment. In addition, improving support from government and non-government organizations through funds is leveling up the market demand. Furthermore, the developed infrastructure of cardiology hospitals is propelling the demand for Coronary Stent Market.

Coronary Stent Market Analysis – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, at present, North America led the global coronary stent market in 2020 and is predicted to continue the domination throughout the forecast period owing to the rapid adoption of the latest technological developments. As a result, the U.S. accounted for most of the North American regional market share in 2020, followed by Canada.

The Asia Pacific is the fastest growing regional market globally for coronary stents. It is expected to showcase the highest CAGR during the forecast period owing to the increasing geriatric population and rise in capital income. In the APAC region, India and China are expected to register the majority of the share during the forecast period.

The European market had a substantial share in the global market in 2020 and is projected to be growing at a prominent CAGR from 2021 to 2026. During the forecast period, UK is estimated to lead the European market, followed by Germany.

The Middle East and Africa are anticipated to have significant growth opportunities in foreseen years with the growing awareness over various treatment procedures.


Notable companies leading the global Coronary Stent Market profiled in the report are Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), BIOTRONIK SE & Co. KG (Germany), B Braun Melsungen AG (Germany), TERUMO CORPORATION (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India) and Translumina GmbH (Germany).


  • In August 2019, Meril Life Sciences received European Conformity for stents. These stents are used for treating coronary artery disease and also for the removal of blockages and lesions.
  • In April 2019, Biotronik announced the PK Papyrus-covered stent system, which is used to contact emergency patients who have coronary holes in the heart. This device has a reduced number of death cases related to coronary artery holes.
  • In May 2019, Medtronic launched the Telescope Guide Extension Catheter, which the FDA approved, and CE. it is to access distal lesions and restore the blood flow through the coronary.
  • In February 2018, Medtronic launched a 2.0 mm drug-eluting stent in the market for those patients who have minor vessel diseases. In addition, the company wants to expand its business in the US Coronary Stent Market.
  • In September 2018, Terumo launched Tansei drug-eluting stent in the Japanese market, already available in the European market.
  • In May 2017, Medtronic, a leading medical devices company, launched a resolute onyx drug-eluting stent and received approval from U.S. FDA for adults’ coronary artery disease. The stent has a large size that enables it to expand for the patients with extra-large vessels.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample